DeepCure

Curated by Signal

AI-driven drug discovery platform for inflammation & immunology space

Overview

AI-driven drug discovery platform for inflammation & immunology space. The company uses a causal ML approach to find binding interactions without biases, enabling the design of truly novel compounds. The company develops a pipeline of therapeutic candidates for inflammation & immunological conditions.

Key facts

Founded: 2018
Headquarters: Boston, United States
Stage: Sign up to view
Industry: Health Technology

Business model

3 products and services: Sign up to view

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Cludaze
Online marketplace offering beauty supplements and wellness products
Health TechnologySan Diego, United States
Bioharmonic Technologies
Provider of vibroacoustic therapy products and systems for wellness and healing
Health TechnologyLos Angeles, United States
KureAI
AI-powered platform to manage medical records and treat diseases
Health TechnologyScottsdale, United States

About DeepCure

What does DeepCure do?

AI-driven drug discovery platform for inflammation & immunology space.

Where is DeepCure headquartered?

DeepCure is headquartered in Boston, United States.

When was DeepCure founded?

DeepCure was founded in 2018.

Which sector is DeepCure in?

DeepCure operates in Health Technology.

Who are DeepCure's competitors?

Companies similar to DeepCure include Cludaze, Bioharmonic Technologies, and KureAI.